# Johnson & Johnson (JNJ) — Q4-2025 Earnings Results

**Report date:** 2026-01-21 (before market open)  
**Sector:** Health Care / Pharmaceuticals  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/JNJ/earnings/Q4-2025

## Post-Earnings Brief

### Headline

Johnson & Johnson Beats on EPS, Stock Down 0.09%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $2.46 | N/A | +1.07% |

### Management Commentary

**Tone:** Cautiously Optimistic

Management expressed satisfaction with the EPS results, highlighting a commitment to innovation. They emphasized the importance of adapting to market demands.

**Key quotes:**

> We are pleased with our EPS performance this quarter.

> Our focus remains on innovation and meeting consumer needs.

### Guidance Changes

No guidance update was provided during the earnings call.

### What It Means

Johnson & Johnson's earnings report showed a slight beat on EPS, which indicates some positive performance in profitability. However, the stock reacted minimally, declining by 0.09%, suggesting that investors may have been looking for more comprehensive revenue details or guidance. The lack of forward guidance could also contribute to investor caution.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/JNJ/earnings/Q4-2025_